Published February 22, 2021
| Version v1
Project deliverable
Open
European study of COVID-19 vaccine effectiveness against hospitalised SARI patients laboratory-confirmed with SARS-CoV-2: I-MOVE-COVID-19 generic protocol
Description
This document presents the core I-MOVE-COVID-19 European protocol for the 2020 hospital-based study of vaccine effectiveness against COVID-19 in hospitalised SARI patients of all ages, outlining the agreed methods for collecting data on COVID-19 and SARS-CoV-2 in each of the individual studies, and including a plan for the pooled analysis.
Notes
This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 101003673
Files
08feb2021_draft_generic_VE_protocol_hospital-based_COVID-19_v07.pdf
Files
(1.2 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:cc16d6c027f8fbe1bd048d11003e3778
|
1.2 MB | Preview Download |